Use of the Material. The RECIPIENT ORGANIZATION shall [1] use the MATERIALS only for the purpose of the Clinical Trial Study; [2] shall not be used in human subjects or COMMERCIAL PURPOSES. DELIVERY OF THE MATERIAL.- The ORIGINAL MATERIAL shall be: [1] delivered by the PROVIDER to the RECIPIENT ORGANIZATION at the expense of the SPONSOR; [2] without identifiable information to any of the Study Participant from whom the ORIGINAL MATERIAL was taken. INTELLECTUAL PROPERTY (IP). - [1] Ownership of IPs derived from the MATERIALS is defined by the Applicable Laws, the Clinical Trial Agreement and the iNFORMED CONSENT of Study Participants; [2] The PARTIES including the Study Participants do not make any implied waiver of any IP Rights accorded by Applicable Laws; [3] Publication. - (a) this Agreement shall not be interpreted to prevent or delay publication of research findings resulting from the use of the MATERIAL unless its publication might be considered as a PRIOR ART which jeopardizes application for patent; and, (b) the PARTY who will publish agrees to provide appropriate acknowledgement of the source of the MATERIAL in all publications. COMPLIANCES WITH LAWS, RULES & REGULATIONS. - The extraction, transfer, and processing of the MATERIALS shall be in compliance with Applicable Laws and the national law where the MATERIALS are transferred.
Appears in 2 contracts
Sources: Material Transfer Agreement, Material Transfer Agreement